CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 40 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $971 | -54.5% | 534 | -55.5% | 0.00% | – |
| Q1 2024 | $2,136 | +1.1% | 1,200 | 0.0% | 0.00% | – |
| Q4 2023 | $2,112 | -39.7% | 1,200 | -50.0% | 0.00% | – |
| Q3 2023 | $3,504 | +39.1% | 2,400 | +118.2% | 0.00% | – |
| Q2 2023 | $2,519 | +151.6% | 1,100 | 0.0% | 0.00% | – |
| Q1 2023 | $1,001 | – | 1,100 | +1000.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 100 | -90.9% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 1,100 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 1,100 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 1,100 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -40.0% | 1,100 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | +66.7% | 1,100 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 1,100 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | -25.0% | 1,100 | +10.0% | 0.00% | – |
| Q4 2020 | $4,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
| Q2 2020 | $3,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $8,910,000 | 1.84% |
| Novo Holdings A/S | 2,927,560 | $7,963,000 | 0.51% |
| Puissance Capital Management LP | 38,010 | $103,000 | 0.44% |
| CHI Advisors LLC | 364,132 | $990,000 | 0.39% |
| BVF INC/IL | 1,742,112 | $4,739,000 | 0.29% |
| Orbimed Advisors | 6,767,584 | $18,408,000 | 0.26% |
| EcoR1 Capital, LLC | 737,612 | $2,006,000 | 0.15% |
| Hikari Power Ltd | 60,959 | $166,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,700 | $364,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 1,192,742 | $3,244,000 | 0.00% |